Abstract
This chapter briefly describes the history of patient surveillance after curative-intent primary treatment for rectal carcinoma. It spans prehistoric times to the present. Notable scientific advances and notable innovators are mentioned.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rando TA, Finkel T. Cardiac aging and rejuvenation – a sense of humors? N Engl J Med. 2013;369:6.
Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–82.
MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341(8843):457–60.
Wu T. Rectal cancer staging. Clin Colon Rectal Surg. 2007;20:148–57.
Cannom RR, Goldberg SM. Evolution of the specialty of colon and rectal surgery: historical perspective. Semin Colon Rectal Surg. 2013;24:187–90.
Gilbertsen VA, Wangensteen OH. A summary of thirteen years’ experience with the second look program. Surg Gynecol Obstet. 1962;144:438–42.
Guy GP, Ekweme DU, Yabroff KR, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31:3749–57.
Vernava AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer: results of a survey of ASCRS members. Dis Colon Rectum. 1994;37:573–83.
Virgo KS, Wade TP, Longo WE, Coplin MA, Vernava AM, Johnson FE. Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists. Ann Surg Oncol. 1995;2:472–82.
Ode K, Patel U, Virgo KS, Audisio RA, Johnson FE. How initial tumor stage affects rectal cancer patient follow-up. Oncol Rep. 2009;21:1511–7.
Simunovic M. Chapter 36. Colon and rectum carcinoma surveillance counterpoint: Canada. In: Patient surveillance after cancer treatment. New York: Humana Press; 2013. p. 201. Table 36.2. ISBN 978-1-60327-968-0.
Johnson FE, Maehara Y, Browman GP, et al. Patient surveillance after cancer treatment. New York: Humana Press; 2013.
Perera JM, Primrose R, Gray A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014;311(3):263–70.
Figueredo A, Rumble R, Maroun J, Earle C, Cummings B, McLeod R, Zuraw L, Zwall C, and the members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence Based-Care. Follow up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3(26):1–13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Johnson, F.E., Priddy, A.M., Johnson, D.Y. (2015). Patient Surveillance After Curative-Intent Treatment for Rectal Carcinoma. In: Longo, W., Reddy, V., Audisio, R. (eds) Modern Management of Cancer of the Rectum. Springer, London. https://doi.org/10.1007/978-1-4471-6609-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6609-2_18
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6608-5
Online ISBN: 978-1-4471-6609-2
eBook Packages: MedicineMedicine (R0)